Altria Group, Inc. (MO) Stock Price, News, Analysis

Technical Score (1D)

BUY

News Sentiment

BULLISH

Altria’s forward price‑to‑earnings ratio now sits at 12.1, a full 3.4 points below the tobacco‑industry average of 15.47 and 7.6 points below the S&P 500’s 19.65, signaling a valuation discount that could attract value‑oriented traders. The discount is reinforced by the company’s recent 9.6 % month‑to‑date gain, outpacing peers such as Philip Morris, Turning Point Brands and British American Bureau, and eclipsing the broader market’s 1.8 % decline. Because the discount is driven by a combination of lower relative valuation and stronger relative performance, it may indicate that the market has not fully priced in Altria’s earnings resilience or its pricing power in a tightening regulatory environment. Over the next 1–10 trading days, the stock could benefit from any positive earnings guidance or regulatory relief that confirms the company’s ability to maintain margins, while a sudden tightening of tobacco regulations or a sharp decline in cigarette demand could erode the valuation premium. Traders should watch the upcoming earnings release for guidance on net sales and cost structure, as well as any statements from the company’s regulatory affairs team regarding pending legislation. Additionally, monitoring the broader tobacco sector’s sentiment—particularly any shifts in consumer preference toward reduced‑risk products—will help gauge whether the discount is likely to persist or widen. Finally, keep an eye on macro‑economic data that could influence discretionary spending, as Altria’s revenue is sensitive to consumer spending cycles.

MO|Analyst Targets

LOW TARGET

$58 -16.8%

2 analysts

MEAN TARGET

$70 +0.4%

13 analysts

HIGH TARGET

$82 +17.7%

9 analysts

PRICE RANGE

$58.00 - $82.00

SB / B / H / S / SS

6/6/9/2/1

DAILYIQ EST.

$70.49 (+1.1%)

MO|Company Info

Sector

Consumer Defensive

Industry

Tobacco

Exchange

NYQ

Country

United States

Website

altria.com

Symbol

Description

Altria Group, Inc. is a U.S.-based company focused on the manufacture and distribution of tobacco products. The company's core business revolves around a portfolio of both smokeable and oral tobacco offerings, including well-known brands like Marlboro cigarettes and Black & Mild cigars. Altria also provides smokeless tobacco products under brands such as Copenhagen and Skoal, in addition to oral nicotine pouches and e-vapor products. Its products are primarily sold to a network of distributors and large retail chains across the United States. Established in 1822 and headquartered in Richmond, Virginia, Altria has a long history in the tobacco industry.

MO|Insider Trading

Bought (1Y)

1,500 shares

$101K

Sold (1Y)

7,790 shares

$563K

McQUADE KATHRYN B.-

Buy1,500 shares2026-09-09

Strahlman Ellen R-

Sell2,000 shares2026-05-26

KELLY ENNIS DEBRA J-

Sell5,790 shares2026-05-26

McQUADE KATHRYN B.-

Award/Grant4,656 shares2026-05-14

YZAGUIRRE MARIO MAX-

Award/Grant2,571 shares2026-05-14

MO|Fundamentals

Neutral / mixed

Verdict: Neutral

✕Revenue declining year over year

✓Positive net margin

✓Positive operating cash flow

Gross Margin

62.5%

Net Margin

29.8%

Revenue CAGR

1.2%

Current Ratio

0.65x

Debt / Equity

-7.34x

Return on Equity

-198.4%

MO|Earnings Snapshot

Earnings Summary

Altria Group, Inc. is a U.S.-based manufacturer and distributor of tobacco products, including cigarettes, cigars, smokeless tobacco, and oral nicotine pouches, operating within the consumer defensive tobacco sector. The company’s core business revolves around well‑known brands such as Marlboro and Black & Mild, with a growing portfolio of oral nicotine products that aim to offset declining cigarette volumes. In recent quarters, Altria has demonstrated a mixed earnings trajectory: Q4 2024 EPS of $1.29 beat the $1.27919 estimate while revenue of $5.106 billion was slightly above the $5.106 billion estimate; Q1 2025 EPS of $1.23 exceeded the $1.18813 estimate and revenue of $4.519 billion was lower than the prior quarter but still above the $4.519 billion estimate. Q2 2025 EPS of $1.44 beat the $1.3848 estimate and revenue of $5.29 billion surpassed the $5.29 billion estimate, whereas Q3 2025 EPS of $1.45 narrowly beat the $1.44818 estimate and revenue of $5.251 billion was slightly below the $5.251 billion estimate. In Q4 2025, EPS of $1.30 fell short of the $1.3575 estimate and revenue of $5.079 billion was below the $5.1905 billion estimate, indicating a deceleration. Q1 2026 EPS of $1.32 missed the $1.47231 estimate and revenue of $4.758 billion was below the $5.295 billion estimate, while Q2 2026 EPS of $1.48 beat the $1.50825 estimate and revenue of $5.356 billion was slightly below the $5.506 billion estimate. Historically, Altria has shown a YoY revenue decline in the 2025–2026 period, with EPS growth fluctuating between modest beats and misses; the company has consistently delivered revenue growth in the face of declining cigarette volumes, but EPS has been more volatile. Recent news highlights a spike in implied volatility on the $32.50 call ahead of the September 18, 2026 earnings release, suggesting market uncertainty around potential regulatory changes and earnings surprises. The FDA approval of four new On! nicotine pouches and expansion to 120,000 retail locations could provide a new revenue stream, but early sales data remain pending. Investors should watch for guidance on pricing strategy and volume trends in the upcoming earnings call, as well as any regulatory announcements that could impact the nicotine‑pouch market, which will be key to understanding the company’s near‑term earnings resilience.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q3'26	$1.51	-	-
Q2'26	$1.51	$1.48	-1.9%
Q1'26	$1.47	$1.32	-10.3%
Q4'25	$1.36	$1.30	-4.2%
Q3'25	$1.45	$1.45	+0.1%
Q2'25	$1.38	$1.44	+4.0%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q3'26	$5.5B	-	-
Q2'26	$5.5B	$5.4B	-2.7%
Q1'26	$5.3B	$4.8B	-10.1%
Q4'25	$5.2B	$5.1B	-2.1%
Q3'25	-	$5.3B	-
Q2'25	-	$5.3B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

MO|Monthly Returns

Market Data

MO Stock Snapshot

HOLD59/100

$69.69+$0.18 (0.3%)

Market cap: 116.56B
P/E ratio: 14.6
Day range: $68.62 – $69.98
News sentiment: 57/100 · Neutral
Analyst target: $70.00 (+0.4%)
Consensus: Hold · 24 analysts

52-week range+27.8% off low · -9.6% from high

$54.51$77.06

Price $69.69 DailyIQ Est. $70.49

The technical read on MO is balanced, which usually means the market is waiting on a catalyst. Earnings and guidance carry more weight than macro data at this capitalisation.

Reverse DCF

What growth is priced into MO?

CHEAP

At today's price, Altria Group, Inc. needs to grow free cash flow about -11.8% a year for the next 10 years to justify its valuation at a 6.00% cost of capital. Over its actual history it has compounded free cash flow at 5.1% a year, so the market is asking for 16.9 percentage points below its own delivered rate. On that basis MO looks priced below what its own growth record supports.

Implied FCF growth: -11.8%
Historical FCF CAGR: 5.1%
Growth gap: -16.9 pts
Verdict: CHEAP
Discount rate (WACC): 6.00%
Beta: 0.30

Behaviour On Record

What MO's own history says about today's numbers

Realized volatility (21d): 19.1% 53rd pct
Below its peak: -9.8%
vs 200-day average: +5.0%
Up days (1y): 53%

Altria Group, Inc. is currently running 19.1% annualised volatility over the last 21 sessions. Measured against MO's own 13 years of daily returns rather than a market-wide average, that is the 53rd percentile — close to its own typical level, against a typical reading of 18.4%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

MO is trading -9.8% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -18.3%, and the deepest was -37.0% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +5.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 58th percentile — a somewhat wider gap than its own norm. Over the past year MO closed higher on 53% of sessions, and it is currently 1 session into a rising streak.

On September specifically: over 13 years of records, MO finished the month higher 4 of 13 times, with a median return of -4.6% and an average of -3.1%. Its strongest month historically has been October at +2.8% on average, its weakest September at -3.1%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: MO has opened more than 2% away from the prior close in 24 of 3,267 sessions (0.7% of the time), with the largest gaps running +4.7% and -5.9%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, MO moved an average of 2.1% in the session after earnings, closing higher 3 of those 3 times, with a median move of +2.3% and a largest of +3.3%.

All figures computed from 3,268 daily closes between 2013-09-18 and 2026-09-16, split-adjusted, recomputed daily. Percentiles are against MO's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of MO's sector?

Altria Group, Inc. sits in the Consumer Staples sector, currently ranked 6th of 11 GICS sectors by relative-strength rotation score (improving).

Sector rank: #6 of 11
Sector state: Improving
Sector rotation score: 60

Options Market

What is the options market pricing for MO?

CallsPuts

For Altria Group, Inc.'s nearest expiry (2026-09-18, 0 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 2.48), with at-the-money implied volatility around 9.0%.

Put/call ratio (2026-09-18): 2.48
ATM implied volatility: 9.0%
Total open interest: 130,272

Analyst Rating Changes

Are analysts turning bullish or bearish on MO?

Barclays most recently reiterated its rating on Altria Group, Inc. to Underweight on Aug 11, 2026 with a price target of $58 (from $64). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action: Barclays — Underweight
90-day upgrades: 0
90-day downgrades: 0
Net rating momentum: 0

Date	Firm	Action	Rating	Price target
Aug 11, 2026	Barclays	Maintained	Underweight	$64 → $58
Jul 7, 2026	UBS	Maintained	Buy	$76 → $79
May 15, 2026	Barclays	Maintained	Underweight	$63 → $64
May 1, 2026	UBS	Maintained	Buy	$74 → $76
May 1, 2026	Citigroup	Maintained	Neutral	$65 → $70
Apr 10, 2026	B of A Securities	Maintained	Buy	$72 → $73
Mar 9, 2026	UBS	Maintained	Buy	$67 → $74
Feb 23, 2026	Barclays	Maintained	Underweight	$57 → $63
Feb 9, 2026	Citigroup	Maintained	Neutral	$57 → $65
Jan 30, 2026	Stifel	Maintained	Buy	$72 → $68
Jan 26, 2026	UBS	Maintained	Buy	$63 → $67
Jan 9, 2026	UBS	Upgrade	Neutral → Buy	$61 → $63

MO Competitive Positioning

Altria Group, Inc. (MO) is tracked alongside these names in Tobacco on DailyIQ — ranked by market cap, with today's move alongside.

MOyou're hereAltria Group, Inc.$116.6B+0.26%
PMPhilip Morris International Inc.$298.8B+0.01%

Held by These ETFs

MO is a top holding in these ETFs tracked on DailyIQ — bar length shows portfolio weight.

News Sentiment Analysis

Sentiment gathered from recent headlines

57/100

Strong NegativeNeutralStrong Positive

MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Altria Group (MO) is trading at a 12.1 forward P/E, below the tobacco industry average of 15.47 and the S&P 500’s 19.65, suggesting a value play. The stock has outperformed its peers—Philip Morris, Turning Point Brands, and British American Bureau—gaining 9.6% in the past month versus 3.9% and 0.7% for the others. MO’s recent performance also eclipsed the broader market, which fell 1.8%. The discount relative to competitors and the sector indicates potential upside if the company maintains its earnings trajectory. Investors should monitor upcoming earnings guidance and any regulatory developments that could affect pricing power.

What did this article say?

Altria’s Q2 adjusted EPS fell short of consensus by two cents, causing a 9% drop in shares. Management simultaneously raised the lower end of full‑year guidance to $5.61–$5.72 per share and increased the quarterly dividend to $1.11, easing the payout ratio to 77%. The company also sued the FDA to accelerate tobacco product reviews, potentially unlocking growth in the oral segment. These actions suggest a short‑term setback but a longer‑term upside for the stock.

What did this article say?

Altria’s long‑term dividend record and higher yield make it attractive for income investors, but British American Tobacco (BTI) is outpacing it on growth, valuation, and smokeless product momentum. BTI’s forward P/E is lower and its modern oral segment has surged, while Altria’s nicotine pouch share has slipped and cigarette volumes are falling. The comparison suggests that while MO offers reliable income, it may lag in growth potential relative to BTI.

What did this article say?

The piece outlines how holding Altria (MO) shares in a Roth IRA can reduce annual tax outlays by keeping dividend income tax‑free. It compares the tax impact of a $500,000 position yielding 8% in a taxable account versus a Roth, showing a $9,600 annual savings at a 24% bracket. The article does not report any earnings, guidance, or operational changes for MO, merely illustrating a tax strategy. Investors should note that the tax benefit is contingent on the current tax bracket and the dividend payout consistency of MO. The analysis does not indicate any material change to MO’s fundamentals or outlook.

What did this article say?

Altria (MO) has gained significant attention on Zacks, with shares up 7.1% in the past month while the broader market fell. The company’s strong performance is tied to rising earnings estimates from sell‑side analysts, reflecting confidence in its future cash flows. Industry peers in tobacco have also outperformed, adding to the positive sentiment around MO. Investors should monitor upcoming earnings releases and any regulatory updates that could affect the company’s valuation.

What did this article say?

The article highlights Altria (MO) as a solid long‑term investment, citing its established business model and attractive dividend yield. It positions MO alongside Coca‑Cola as a dependable, time‑tested stock suitable for a decade‑long hold. The piece underscores the company’s stable cash flow and consistent dividend payments as key reasons for its recommendation. Investors should note that the recommendation is based on long‑term fundamentals rather than short‑term market swings.

What did this article say?

Altria has announced a substantial return of capital to shareholders, distributing billions in dividends and share buybacks. The move signals a strong cash position but may also indicate limited growth opportunities or a strategic shift toward shareholder value. Investors should assess whether the capital return is sustainable and how it affects future earnings and dividend policy. The announcement could influence MO’s valuation if the market interprets it as a sign of financial strength or a lack of reinvestment prospects. Monitoring subsequent earnings releases and cash flow statements will clarify the long‑term impact.

What did this article say?

Nicole Saphier, the former Surgeon General, has publicly invested in Altria, Philip Morris International, and British American Tobacco, signaling confidence in the tobacco sector. Her endorsement may enhance investor perception of Altria’s stability and growth prospects, especially amid regulatory scrutiny. The investment could attract additional institutional interest and support the company’s dividend strategy. Traders should watch for any subsequent commentary from Saphier or related regulatory developments that could influence market sentiment. The endorsement also underscores Altria’s positioning within a broader portfolio of tobacco stocks favored by influential figures.

What did this article say?

The article highlights Altria (MO) as a compelling dividend‑paying value play in a high‑yield environment where Treasury rates exceed 5%. MO’s strong cash flow and dominant Marlboro brand position it to maintain dividend payouts even as smoking rates decline. The piece frames MO as a low‑risk alternative to higher‑yield CDs and T‑bills, suggesting it could outperform the broader market in a tightening rate cycle.

What did this article say?

Altria Group (MO) reported a 4.5% price realization in Q2 2026, driven largely by Marlboro’s 7% retail price increase. Despite this, domestic cigarette shipments fell 3.2% and adjusted trade inventory movements added a 4.5% decline, indicating ongoing volume pressure. Net revenues rose 2% and adjusted OCI margin expanded to 64.8%, showing that pricing strength is offsetting some volume losses. The mix shift toward discount retail shares increased by 2.6 percentage points, while Marlboro’s premium share remained steady at 59.6%. Overall, the company’s pricing strategy is delivering modest upside, but the volume decline signals a potential headwind that could temper future earnings growth.

Technical Analysis

Real-time indicators across multiple timeframes

NEUTRAL

Technical indicators reflect the latest computed signal mix for this timeframe.

Unlock full technicals

Create a free account to access more indicators and deeper timeframe data.

Institutional & Hedge Fund Ownership

25 tracked managers · $37.65B combined position · 14 adding, 10 trimming, 1 unchanged (latest 13F filings)

Manager	Trend	Shares Held	% of Co.	Position Value	Filed
Vanguard Group Inc	▲ Buy	160,980,626	9.62%	$9.28B	2026-01-29
BlackRock, Inc.	▲ Buy	126,073,166	7.54%	$9.07B	2026-08-07
Capital Research Global Investors	▲ Buy	58,653,624	3.51%	$4.22B	2026-08-12
Geode Capital Management, LLC	▲ Buy	47,721,870	2.85%	$3.44B	2026-08-12
Morgan Stanley	▼ Sell	22,702,935	1.36%	$1.63B	2026-08-13
Capital World Investors	▲ Buy	18,480,673	1.10%	$1.33B	2026-08-12
Northern Trust Corp	▼ Sell	15,604,968	0.93%	$1.12B	2026-08-13
Bank of America Corp	▲ Buy	15,351,862	0.92%	$1.10B	2026-08-14
Goldman Sachs Group Inc	▲ Buy	13,929,842	0.83%	$1.00B	2026-08-14
JPMorgan Chase & Co	▼ Sell	12,207,565	0.73%	$903.97M	2026-08-12
Invesco Ltd.	▼ Sell	11,724,425	0.70%	$843.57M	2026-08-14
Susquehanna International Group, LLP	▼ Sell	7,945,713	0.48%	$571.69M	2026-08-14
Citadel Advisors LLC	• Hold	6,394,157	0.38%	$460.06M	2026-09-02
FMR LLC (Fidelity)	▲ Buy	6,010,922	0.36%	$432.49M	2026-08-13
AQR Capital Management LLC	▲ Buy	5,940,353	0.36%	$427.41M	2026-08-14
Wells Fargo & Company	▲ Buy	5,697,294	0.34%	$409.92M	2026-08-14
Marshall Wace, LLP	▲ Buy	5,006,159	0.30%	$360.19M	2026-08-13
D. E. Shaw & Co., Inc.	▼ Sell	2,794,465	0.17%	$201.06M	2026-08-14
Citigroup Inc	▼ Sell	1,953,495	0.12%	$140.55M	2026-08-03
Millennium Management LLC	▼ Sell	1,845,801	0.11%	$132.81M	2026-08-14
Renaissance Technologies LLC	▲ Buy	1,781,400	0.11%	$128.17M	2026-08-13
AllianceBernstein L.P.	▲ Buy	1,890,884	0.11%	$124.78M	2026-08-14
Bridgewater Associates, LP	▲ Buy	1,727,216	0.10%	$124.27M	2026-08-14
Adage Capital Partners GP, L.L.C.	▼ Sell	1,488,332	0.09%	$107.09M	2026-08-14
Point72 Asset Management, L.P.	▼ Sell	1,105,900	0.07%	$79.57M	2026-08-14

Q2 2026 flow:38.36M sh bought ($2.76B)7.09M sh sold ($511.96M)net +31.27M sh (+$2.25B)

Congressional Trading Activity

1 disclosed trades · ~$8.0K est. traded value · 0 buys, 1 sells

Member	Chamber	State	Type	Amount	Traded	Filed
Sheri Biggs	House	SC03	▼ Sell	$1K - $15K	2025-03-19	2025-10-05

MO·Altria Group, Inc.

EPS

Revenue

MO Stock Snapshot

What growth is priced into MO?

What MO's own history says about today's numbers

Is money rotating into or out of MO's sector?

What is the options market pricing for MO?

Are analysts turning bullish or bearish on MO?

MO Competitive Positioning

Held by These ETFs

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

Market Status

Recently Viewed

Portfolio

Email Alerts

Portfolio News

Economic Events

Earnings Events

Economic News

MO·Altria Group, Inc.

EPS

Revenue

MO Stock Snapshot

What growth is priced into MO?

What MO's own history says about today's numbers

Is money rotating into or out of MO's sector?

What is the options market pricing for MO?

Are analysts turning bullish or bearish on MO?

MO Competitive Positioning

Held by These ETFs

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

Discover More

News Sentiment Analysis

Recent News Coverage

Technical Analysis

Real-time indicators across multiple timeframes

Discover More

Market Status

Recently Viewed

Portfolio

Email Alerts

Portfolio News

Economic Events

Earnings Events

Economic News